Targeting of MAD2L1 by miR‐515‐5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells

Abstract

Although many previous studies have found that the mitotic arrest deficient 2-like 1 (MAD2L1) protein contributes to the proliferation of colorectal cancer (CRC) cells, but the upstream mechanism of MAD2L1 is still largely elusive. This study aimed to explore the microRNAs (miRNAs) upstream of MAD2L1 to improve our understanding of the mechanism of the MAD2L1 gene in CRC. The upstream target miRNAs (miR-515-5p) of MAD2L1 were predicted by the online databases miRWalk, miRDIP, and TargetScan. Quantitative real-time PCR (qRT-PCR) was used to detect the expression level of miR-515-5p in human CRC tissues. The targeting relationship between miR-515-5p and MAD2L1 was tested by dual luciferase reporter gene assays. The effects of miR-515-5p on the biological behaviors of CRC cells by regulating MAD2L1 expression were verified by qRT-PCR, western blot, Cell Counting Kit-8, and flow cytometry. The results showed that miR-515-5p was a highly reliable upstream miRNA of the MAD2L1 gene. As an upstream target miRNA of MAD2L1, miR-515-5p was lowly expression in CRC tissues. The overexpression of miR-515-5p could inhibit the proliferation of CRC cells and induce cell cycle arrest at the G1 phase leading to cell apoptosis. However, MAD2L1 gene overexpression could reverse the effects of miR-515-5p overexpression on the biological behaviors of CRC cells above. This study illustrated that miR-515-5p can inhibit proliferation and induce G1 phase arrest leading to apoptosis in CRC cells. The mechanism underlying this phenomenon may be related to the negative targeted regulation of MAD2L1.

MAD2L1 Promotes Ewing's Sarcoma Progression Through AURKA/MYC Axis

“…After analyzing clinical samples, the experimental model was utilized to search for further support. We found that knockdown of MAD2L1 signi cantly decreased proliferation and promoted apoptosis of ES cells in vitro and in vivo, in line with previous reports that MAD2L1 acts as an oncogene in various cancers, including gastric cancer, rhabdomyosarcoma, and colorectal cancer [25,29,30]. Xia et al revealed that MAD2L1 promotes the proliferation and migration of rhabdomyosarcoma cells [14].…”

Exploring the pathogenesis of colorectal carcinoma complicated with hepatocellular carcinoma via microarray data analysis

“…In previous studies, the differential expression of MAD2L1 in many tumors was analyzed using the TIMER2.0 database ( Chen et al, 2020 ). For CRC, the higher expression of MAD2L1 has been observed to counteract the repressive impact of miR-515-5p overexpression on the proliferation of colorectal cancer cells, as well as the induction of apoptosis and G1-phase detainment ( Ding et al, 2022 ). However, survival analysis showed high expression of MAD2L1 in HCC correlated with shorter OS.…”

Exploring the Relationship Between Senescence and Colorectal Cancer in Prognosis, Immunity, and Treatment

“…MAD2L1, as a member of the spindle checkpoint functional complex, plays a crucial role in cell cycle regulation ( Zhong et al, 2015 ). MAD2L1 has been reported as a novel oncogene that plays a role in regulating cancer cell growth and apoptosis ( Ding et al, 2020 ; Ding et al, 2022 ). NDRG1 has been reported to act as a metastasis suppressor ( Bae et al, 2013 ; Sahni et al, 2014 ).…”